News
This was the stock's third consecutive day of losses.
Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...
Long-term shareholders have already seen significant gains from these stocks, and there's likely much more to come for ...
19h
MedPage Today on MSNCaution Advised With Upfront SGLT2 Inhibitor-MRA Combo for Heart FailureIncluded in the open-label crossover SOGALDI-PEF study were adults with symptomatic heart failure (New York Heart Association ...
Amgen Inc. (NASDAQ:AMGN) is one of the top low volatility healthcare stocks to buy now. On July 23, BofA analyst Tim Anderson ...
In a recently-issued Director Discretionary Denial decision, U.S. Patent and Trademark Office (USPTO) Acting Director Coke ...
10h
Zacks Investment Research on MSNAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should KnowAmgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...
In this Healio Video Perspective from the Retina World Congress, Ashish Sharma, MBBS, MS, gives an update on aflibercept ...
Promising Ewing Sarcoma Pipeline Therapies such as Vigil, Temozolomide, Irinotecan, CP-751,871, Eribulin mesylate, ...
As many as 19 of the top 20 publicly-traded global biopharma companies reported revenue growth in 2024, with an overall 7.9% ...
The importance of a homegrown biomanufacturing workforce to North Carolina’s swiftly growing life sciences industry was a consistent theme during a recent press tour of the state attended by Fierce | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results